title: Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin.
abstract: Mineral dust-induced gene (mdig) had been linked to the development of human lung cancers associated with environmental exposure to mineral dust, tobacco smoke or other carcinogens. In the present studies, we demonstrated that the overexpression of mdig in A549 adenocarcinomic human alveolar type II epithelial cells decreases the heterochromatin conformation of the cells and de-represses the transcription of genes in the tandemly repeated DNA regions. Although mdig can only cause a marginal decrease of the total histone H3 lysine 9 trimethylation (H3K9me3), a significant reduction of H3K9me3 in the promoter region of H19, the paternally imprinted but maternally expressed gene transcribing a large intergenic non-coding RNA (lincRNA), was observed in the cells with mdig overexpression. Silencing mdig by either shRNA or siRNA not only increased the level of H3K9me3 in the promoter region of H19 but also attenuated the transcription of H19 long non-coding RNA. Demethylation assays using immunoprecipitated mdig and histone H3 peptide substrate suggested that mdig is able to remove the methyl groups from H3K9me3. Clinically, we found that higher levels of mdig and H19 expression correlate with poorer survival of the lung cancer patients. Taken together, our results imply that mdig is involved in the regulation of H3K9me3 to influence the heterochromatin structure of the genome and the expression of genes important for cell growth or transformation.
authors: Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy, Wayne State University, 259 Mack Avenue, Detroit, MI, USA.
authors: Bailing
authors: B
authors: Chen
authors: Miaomiao
authors: M
authors: Yu
authors: Qingshan
authors: Q
authors: Chang
authors: Yongju
authors: Y
authors: Lu
authors: Chitra
authors: C
authors: Thakur
authors: Danjun
authors: D
authors: Ma
authors: Zhenping
authors: Z
authors: Yi
authors: Fei
authors: F
authors: Chen
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism; D000077192:Adenocarcinoma of Lung; D045744:Cell Line, Tumor; D049308:Dioxygenases; D015536:Down-Regulation; D006570:Heterochromatin / Q000235:genetics* / Q000378:metabolism; D056466:Histone Demethylases; D006657:Histones / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism; D008745:Methylation; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D062085:RNA, Long Noncoding / Q000235:genetics* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics; D016019:Survival Analysis; D014158:Transcription, Genetic; D014162:Transfection
chemical_list: C094335:H19 long non-coding RNA; D006570:Heterochromatin; D006657:Histones; D009687:Nuclear Proteins; D062085:RNA, Long Noncoding; D034741:RNA, Small Interfering; D049308:Dioxygenases; D056466:Histone Demethylases; C466777:RIOX2 protein, human
references: Epigenetics. 2012 Aug;7(8):811-4
references: 22735386
references: J Hepatol. 2009 Feb;50(2):323-33
references: 19041150
references: Mol Reprod Dev. 1997 Mar;46(3):419-39
references: 9041146
references: Endocr Relat Cancer. 2012 Apr 10;19(2):197-208
references: 22277193
references: Int J Biol Markers. 2008 Apr-Jun;23(2):83-8
references: 18629780
references: Pathol Int. 2007 Oct;57(10):672-80
references: 17803656
references: Nat Cell Biol. 2012 Jun 10;14(7):659-65
references: 22684254
references: Nat Rev Cancer. 2010 Jul;10(7):457-69
references: 20574448
references: Clin Cancer Res. 2004 Nov 1;10(21):7347-56
references: 15534111
references: Carcinogenesis. 2002 Nov;23(11):1885-95
references: 12419837
references: Oncogene. 2005 Jul 21;24(31):4873-82
references: 15897898
references: Am J Pathol. 2004 Jan;164(1):205-16
references: 14695334
references: J Pediatr Surg. 2007 Nov;42(11):1831-40
references: 18022432
references: Hepatol Res. 2010 Apr;40(4):330-6
references: 20070393
references: J Biol Chem. 2002 Sep 20;277(38):35450-9
references: 12091391
references: EMBO J. 2010 Jul 7;29(13):2135-46
references: 20168299
references: Nat Immunol. 2009 Aug;10(8):872-9
references: 19561615
references: Cell. 2006 May 5;125(3):483-95
references: 16603237
references: Genes Dev. 2011 Apr 1;25(7):673-8
references: 21460035
references: Int J Mol Sci. 2013 Feb 21;14(2):4298-316
references: 23429271
references: Nat Rev Mol Cell Biol. 2009 Aug;10(8):526-37
references: 19603040
references: Nat Rev Genet. 2006 Sep;7(9):715-27
references: 16983801
references: Oncol Rep. 2007 Oct;18(4):841-8
references: 17786344
references: Nature. 1991 May 9;351(6322):153-5
references: 1709450
references: Hum Mol Genet. 2012 Oct 15;21(20):4367-77
references: 22791747
references: Front Genet. 2012 Oct 15;3:214
references: 23087708
references: Cell. 2001 Nov 2;107(3):323-37
references: 11701123
references: Genes Dev. 2000 May 15;14(10):1186-95
references: 10817754
references: Nat Chem Biol. 2012 Dec;8(12):960-962
references: 23103944
references: Nature. 2006 Jul 20;442(7100):312-6
references: 16732292
references: Cell Cycle. 2009 Jul 1;8(13):2101-9
references: 19502796
references: Hum Mol Genet. 2011 Apr 1;20(7):1363-74
references: 21282187
references: Nature. 1993 Oct 21;365(6448):764-7
references: 7692308
references: Cancer Res. 2006 May 15;66(10):5330-7
references: 16707459
references: Mol Cancer. 2009 Aug 17;8:64
references: 19686584
references: Eur J Cell Biol. 2005 Mar;84(2-3):279-94
references: 15819408
references: Oncol Lett. 2012 May;3(5):1037-1041
references: 22783387
references: Carcinogenesis. 2010 Mar;31(3):350-8
references: 19926638
references: Kurume Med J. 2006;53(3-4):71-8
references: 17317935
references: Nat Rev Genet. 2011 Feb;12(2):123-35
references: 21221116
references: Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10684-9
references: 16815976
references: Genes Dev. 1993 Sep;7(9):1663-73
references: 7690336